Peter Kolchinsky, Director at Cytek Biosciences, Inc. (CTKB), bought 8,100,751 shares at $17.00 ($50.1M) on 2021-07-27, disclosed to the SEC on 2021-07-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,150,751 | $0 | 0.0% |
| 2 | $17.00 | 187,214 | $3.2M | 6.3% |
| 3 | $17.00 | 2,762,786 | $47.0M | 93.7% |
| Total | $6.19 avg | 8,100,751 | $50.1M | 100% |
| Filing → |
| VOR | SELL | 2025-10-30 | $20.7M | — | Filing → |
| CDTX | BUY | 2025-06-30 | $100.0M | — | Filing → |
| TYRA | BUY | 2025-06-06 | $23.5M | — | Filing → |